Chapter 166: Chapter 166: Animal trials
STARR BIOLOGY - BIOSAFETY FACILITY - 11:00 PM (FLASHBACK TO A FEW HOUR AGO)
Dr. Sarah Chen stared at the gene enhancent serum formula on her display—thirty-four active components, zero predicted side effects, revolutionary benefits that seed too good to be true—and made a decision that bypassed every standard protocol she’d followed in thirty years of dical research.
"We’re testing this tonight," she announced to the empty laboratory, then imdiately opened a group ssage to her entire research team, "Ergency eting in Lab 3 in thirty minutes—we have gene enhancent serum ready for biological verification and I refuse to wait another day when we could be confirming this works."
Her phone erupted with responses within seconds—fifteen scientists who should have been sleeping but were instead clearly awake and thinking about the sa thing she was.
Dr. Jas Wright: "Finally! I’ve been running simulations all evening. On my way."
Dr. Elena Kowalski: "Bringing my analysis equipnt. See you in twenty."
Dr. Marcus Obi: "Should we wait for proper authorization?"
Dr. Chen typed back imdiately: "We have Rene’s authorization and Orion’s standing directive to move fast on priority technologies—gene enhancent is priority one, and we’re not waiting for bureaucratic approval when we can verify tonight."
By 11:30 PM the entire team had assembled in the advanced biological laboratory that Orion had used for his own experints—the facility was extraordinary, containing equipnt that made their previous research institutions look primitive by comparison, everything they could possibly need for comprehensive testing already present and functional.
"Here’s what we’re doing," Dr. Chen said with decisive authority, pointing at different team mbers, "Wright, you contact every major zoo within 500 kiloters and request terminal animals scheduled for euthanasia—we need twenty subjects minimum, various species, mix of healthy and sick—offer them whatever money is necessary to fast-track the process, I don’t care about paperwork delays, just get us test subjects by morning."
Dr. Wright was already on his phone, pulling up zoo contact lists.
"Kowalski, you set up comprehensive monitoring equipnt throughout the lab—I want real-ti tracking of every biological parater we can asure, video docuntation, cellular analysis capability, genetic sequencing ready to go—this needs to be the most thoroughly docunted biological test in history."
Dr. Kowalski moved imdiately to the equipnt stations, her team following.
"Obi, you import the gene serum molecular blueprint into the Mark III replicators and manufacture twenty batches—we need enough for all test subjects plus backup samples for analysis—manufacturing should take what, thirty minutes maximum?"
"Less," Dr. Obi confird, already heading to the replicator interface, "Mark IIIs can produce complex biologics in minutes—I’ll have twenty batches ready within the hour, each one precisely matching Rene’s formula."
"Everyone else," Dr. Chen continued, addressing the remaining team mbers, "prepare examination stations, sterilize equipnt, set up post-injection monitoring protocols, organize data collection systems—when those animals arrive tomorrow morning I want to inject them imdiately and track results in real-ti."
The team dispersed to their assigned tasks with the focused energy of people who knew they were participating in sothing historic, and Dr. Chen pulled up the serum specifications on the main laboratory display to review one more ti before they committed to biological testing.
Thirty-four components. Tripled lifespan. Doubled physical and cognitive capability. Disease reversal. Cellular regeneration. Zero predicted adverse effects.
"If this works," she whispered to herself, "if the simulations are accurate and this serum does what it claims, we’re not just curing diseases—we’re upgrading humanity itself, and nothing in dicine will ever be the sa."
Dr. Obi called from the replicator station: "First batch complete—formula replication perfect, molecular structure matches Rene’s specifications exactly—continuing production of remaining nineteen batches."
Dr. Wright looked up from his phone: "tro Zoo has eight animals scheduled for euthanasia this week—three elderly primates with organ failure, two big cats with terminal cancers, three others with various conditions—they’re accepting 50,000 credits to fast-track the transfer, animals will be here by 6 AM."
"Excellent," Dr. Chen approved, "keep calling—I want twenty subjects minimum, preferably twenty-five for statistical significance."
The laboratory transford over the next three hours: monitoring equipnt calibrated and tested, examination stations prepared with surgical precision, data collection systems integrated and verified, and twenty batches of gene enhancent serum sitting in temperature-controlled storage waiting for test subjects to arrive.
By 2:30 AM everything was ready, and the exhausted but exhilarated research team gathered around the main display to review their testing protocol one final ti.
"Animals arrive at 6 AM," Dr. Chen summarized, "we conduct baseline examinations imdiately—full dical workup, imaging, blood work, genetic sequencing, behavioral assessnt—then we administer the serum and monitor continuously for imdiate effects."
"How fast do we expect results?" Dr. Kowalski asked.
"Rene’s simulations predict effects begin within minutes," Dr. Chen said, and the number made everyone’s eyes widen because therapeutic effects that manifested in minutes rather than days or weeks were essentially unheard of in genetic dicine, "cellular changes should be visible almost imdiately, systemic effects within the first hour, and complete transformation within twenty-four hours."
"Minutes," Dr. Wright repeated with wonder, "we’re going to actually see terminal illnesses reversing in real-ti, watch organs regenerating, observe genetic corrections happening—this isn’t standard dical research, this is witnessing miracles."
"It’s witnessing science," Dr. Chen corrected gently, "extraordinarily advanced science that looks like miracles because we’re so far ahead of normal dical capability—but it’s still biology following natural laws, just enhanced through technology we didn’t have before."
She checked the ti: 2:47 AM. Three hours until animals arrived. Three hours until they’d know whether Rene’s perfect simulations translated to perfect biological reality.
"Everyone get a few hours of rest," she ordered, "sleep in the breakroom if you want to stay close—we need to be sharp and focused when testing begins, and running on pure adrenaline isn’t sustainable."
The team dispersed reluctantly, too excited to sleep but recognizing the wisdom of rest before the most important experint of their careers.
Dr. Chen remained in the laboratory alone, staring at the twenty batches of serum that might change everything, and allowed herself a mont of hope that after thirty years chasing dical breakthroughs, she might finally be holding the one that actually delivered on its promises.
Three hours until they’d know.
Three hours until science either confird the impossible or revealed hidden flaws.
Three hours until the future arrived.
6:00 AM - TEST SUBJECTS ARRIVE
The terminal animals arrived in specialized transport vehicles—twenty-three subjects total from four different facilities, each one tagged with dical histories and conditions that made them candidates for euthanasia.
Dr. Chen’s team worked with systematic efficiency: animals transferred to individual examination chambers, baseline vitals recorded, comprehensive dical imaging conducted, blood samples collected for genetic sequencing, behavioral observations docunted.
Subject A-1: Elderly chimpanzee, kidney failure, two weeks estimated survival Subject A-2: Bengal tiger, tastatic bone cancer, days estimated survival
Subject A-3: Aged elephant, heart disease, declining rapidly Subject A-4: Rhesus monkey, genetic disorder, chronic pain [...and nineteen more subjects with various terminal or severe conditions...]
"Baseline examinations complete," Dr. Kowalski reported at 8:15 AM, "all subjects docunted, conditions verified, dical status confird—we’re ready for serum administration."
Dr. Chen stood in the center of the laboratory surrounded by monitoring stations showing twenty-three different animals, each one dying or suffering, each one about to receive treatnt that would either save them or confirm the serum didn’t work as promised.
"Beginning administration," she announced for the recording systems, preparing the first injection, "Subject A-1, terminal kidney failure, administering gene enhancent serum at species-appropriate dosage—mark ti 6:30 AM."
The injection was subcutaneous in the chimpanzee’s arm, and the animal barely reacted to the needle stick, too sick to care about minor discomfort.
And then they waited.
According to Rene’s simulations, effects should begin within minutes.
Dr. Chen watched the monitoring displays with her heart hamring, waiting for sothing to happen, so sign that the serum was working or failing or doing anything at all—
At 8:19 AM—two minutes after injection—Subject A-1’s cellular biomarkers began changing on the molecular scanners.
"Genetic transcription activating," Dr. Wright called out with excitent breaking through professional composure, "DNA modifications beginning, cellular repair chanisms engaging—it’s working, Sarah, the serum is actually working!"
They worked through the night with systematic thoroughness: advanced MRI showing tumors that had shrunk to negligible sizes, biopsies revealing healthy pancreatic tissue where malignant cells had been, genetic sequencing showing permanent DNA modifications that corrected the mutations responsible for cancer developnt, and blood markers indicating immune system function that had improved dramatically from pre-treatnt baseline.
"The cancer isn’t in remission," Dr. Kowalski said with wonder making her voice shake slightly, "it’s eliminated—the immune system learned to recognize malignant cells and destroyed them systematically, and the genetic modifications prevent new cancer formation by correcting the underlying DNA damage that allowed tumors in the first place."
They moved through all ten monkeys, each examination revealing similar miraculous results: kidneys regenerating in Subject A-4 who’d had complete renal failure, genetic disorders corrected at DNA level in Subject A-6, immune dysfunction resolved in Subject M-8, and across every case the pattern was identical—permanent genetic enhancent that didn’t just treat symptoms but corrected root causes.
Reviews
All reviews (0)